Rilonacept to Improve Artery Function in Patients With Atherosclerosis

Clinical trial NCT00417417 · COMPLETED

Trial details

NCT number: NCT00417417
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease Atherosclerosis Inflammation Endothelial Dysfunction

Start date: 2006-12-01
Primary completion: 2008-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.